HK Stock Market Move | Shanghai Pharmaceuticals Holding (02607) fell by more than 5%, with an increase in asset impairment provisions. Net profit for the third quarter decreased by 38.13% year-on-year.

Shanghai Pharmaceuticals Holding (02607) fell more than 5%, with a decline of 5.11% as of the time of writing, at 11.71 Hong Kong dollars, with a turnover of 1.09 billion Hong Kong dollars. In terms of news, Shanghai Pharmaceuticals Holding released its third quarter report for 2025. From January to September 2025, the company achieved operating income of 215.072 billion yuan, a year-on-year increase of 2.60%; the company achieved a net profit attributable to shareholders of the listed company of 5.147 billion yuan, a year-on-year increase of 26.96%. Looking at the third quarter alone, the company achieved operating income of 73.479 billion yuan, a year-on-year increase of 4.65%; net profit attributable to shareholders was 688 million yuan, a year-on-year decrease of 38.13%, mainly due to an increase in asset impairment provisions recognized in this quarter.